1
Return

Development and Value of a Centralized Text Message-based Tracking and Support Program for the PRECIDENTD Study

delete2026-01-08
delete0
delete
OA
AI
L
Lyndsay A. Nelson *
E
Erin M. Bergner *
A
Amos Adler
C
Charles Yoon
K
Kathleen Mieras
E
Ed Simeone
J
Jeremy Lema-Driscoll
B
Brendan M. Everett
D
Deborah J. Wexler
L
Lindsay S. Mayberry *
DOI：10.1097/MLR.0000000000002246delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
PRECIDENTD (PRevention of CardIovascular and DiabEtic KidNey Disease in Type 2 Diabetes) is a PCORnet® Study evaluating 2 classes of medications, SGLT2 inhibitors and GLP-1 receptor agonists, among people with type 2 diabetes. Participants obtain their assigned medication through their health insurance and complete semi-annual study assessments.
Keywords:
technology
comparative studies
adherence
randomized trial
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

M
Medical Care
IF:
2.8
Papers:
6.8K
Citations:
2.0W

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers